NCT07911501Not yet recruitingPhase 4
Perioperative Dutasteride for Hemorrhage Control in Bipolar TURP Under Anticoagulation.
Perioperative Dutasteride Effect on Perioperative Haemorrhage During Bipolar Transurethral Resection of the Prostate in Anticoagulated Patients.
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
A prospective, randomized, double-blinded controlled trial to evaluate the efficacy of a 2-week preoperative and 2-week postoperative course of oral dutasteride (0.5 mg daily) in reducing perioperative blood loss, irrigation requirements, and catheterization time in patients on anticoagulant therapy undergoing bipolar TURP for benign prostatic hyperplasia (BPH).
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- First submitted
- 21 Oct 2026
- Start date
- 21 Oct 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Mohamed Mahmoud Dogha
- NCT number
- NCT07911501
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 44
- From 21 Oct 2026 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant urethral stricture.
- Previous prostatic surgical or endoscopic procedures.
Other illness
- Known or suspected prostate cancer.
- High-risk cardiac condition.
- Severe hepatic impairment or significant liver disease.
- Severe renal impairment (including patients on hemodialysis).
- Active, untreated urinary tract infection.
Who the study is looking for
- 1 - Male patients aged \> 50 years. 2-Patients currently receiving oral anticoagulant or antiplatelet therapy. 3- Scheduled for bipolar TURP for symptomatic benign prostatic hyperplasia. 4-Prostate size \> 50 g (measured by pelvi-abdominal or transrectal ultrasonography).
Age in the registry: 50 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mohamed Mahmoud Dogha Coordinator of this site? Confirm its status | Al Fayyum | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.